Hydrazino-type N.sub.2 S.sub.2 radionuclide chelating compounds
US5858327A · kind A · utility
3Cited by
22References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 1996 |
| Grant date | Jan 12, 1999 |
| Priority date | — |
| Expiry date | Mar 8, 2016 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/534
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.